Oral manifestations of cutaneous T-cell lymphoma

David Sirois(Rutgers, The State University of New Jersey), Eric C. Vonderheid(Ashford and St Peter's Hospitals NHS Foundation Trust), Robert D. Harwick(Temple University Hospital)

Oral Surgery Oral Medicine Oral Pathology

June 1, 1993

10.1016/0030-4220(93)90426-5

Cited by 51

Related Papers

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

|Blood|2007|1.4k

Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy

|New England Journal of Medicine|1987|1.2k

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

|Journal of Clinical Oncology|2011|657

Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

|Journal of Clinical Oncology|2001|610

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

|Journal of the American Academy of Dermatology|2008|597